洞察斯芬戈-1-酸盐受体调节剂以及对心血管疗法的影响
Yu-Xin Xie1,2, Hui Yao2, Jin-Fu Peng1,2
1Hunan province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.
素1-酸盐 (S1P) 调节剂通过调节S1P受体,显示出对心血管疾病的治疗潜力. 本综述探讨了它们对动脉样硬化和心肌梗塞等疾病的影响.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 脂质信号传递的方法
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 斯芬戈-1-酸盐 (S1P) 是一种生物活性脂质,调节关键的细胞过程.
- 通过Sphingosine 1-phosphate受体 (S1PRs) 传递S1P信号,影响心血管生理学.
研究的目的:
- 审查五种斯芬辛1-酸盐受体 (S1PRs) 和它们的功能.
- 总结一下神素1-酸盐受体 (S1PR) 调节器的进展情况.
- 专注于S1PR调节器在心血管疾病中的治疗潜力.
主要方法:
- 对S1P,S1PRs和S1PR调节器现有研究的文献综述.
- 分析S1PR调节器与S1PR亚型 (agonists和antagonists) 的相互作用.
- 专注于S1PR调节器对特定心血管疾病的影响.
主要成果:
- 通过S1PRs,S1P在心血管系统中起着保护作用.
- S1PR调节器显示出潜在的治疗应用.
- 对动脉样硬化,心肌梗塞,缺血/再输损伤,糖尿病心血管疾病和心肌炎的影响进行了审查.
结论:
- S1PR调节器代表了治疗心血管疾病的有前途的治疗类.
- 了解S1PR的功能,可以了解新的治疗策略.
- 对S1PR调节器的进一步研究可能会产生有价值的临床益处.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
12:48Microperfusion Technique to Investigate Regulation of Microvessel Permeability in Rat Mesentery
Published on: September 12, 2015
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Amplifying Signals via Second Messengers
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
